Confidential mandate
IPO Finance Readiness Governance Director
Planned Hiring / New
IPO Finance Readiness Governance Director mandate in Tel Aviv, Israel
Confidential IPO Finance Readiness Governance Director in Tel Aviv, Israel, reporting to the Chief Financial Officer. Advisory Finance & Accounting appointment at Director level, a 8-month mandate horizon; three days a week.
The mandate
The adviser will help finance leadership assess readiness for a potential public-market path without implying any issuer, market, timing or transaction status in this publication. The standing question is whether finance can produce timely, governed evidence and sustain public-company disciplines, not whether a project plan reports green or advisers have completed their own workstreams.
Three days each week will cover a weekly readiness clinic, independent review of evidence and one monthly steering session. The director will challenge close, reporting, controls, forecast governance, policy ownership, finance talent and transaction workstream dependencies. Management and appointed professional advisers retain execution and formal opinions.
Readiness will be tested through repeatable operating evidence. A document created once for diligence does not demonstrate an embedded control; a compressed close rehearsal that depends on extraordinary effort is not sustainable. The adviser will identify conditions under which finance should proceed, pause or narrow ambition, and will represent uncertainty rather than manufacture confidence.
The role has no line authority and no transaction, accounting-policy, audit, legal, banking or investor-communication authority. It will not select advisers or certify readiness. Any relationship with advisers, exchanges, investors or service firms that could benefit from a transaction must be disclosed and managed before access.
By month eight, the executive team should have a defensible readiness opinion, evidence gaps by consequence, and an owner-led plan for sustaining required disciplines. The final advice will state assumptions, unresolved dependencies and any areas where a public timetable would require risk acceptance rather than proven capability.
What you will own
- Define readiness criteria across close, reporting, controls, forecasting, policy, talent, governance and supporting evidence.
- Distinguish one-time project production from repeatable operating capability through rehearsal and cycle evidence.
- Challenge workstream status where completion lacks quality, ownership, sustainability or integrated dependency proof.
- Frame proceed, pause and conditional options with consequences, evidence needs and next decision dates.
- Review readiness of finance leadership capacity and succession without selecting or assessing named candidates publicly.
- Identify extraordinary effort embedded in rehearsals and require a credible sustainable operating model.
- Advise management on evidence and risk; formal accounting, legal, audit and transaction opinions remain with authorised parties.
- Deliver an independent final readiness view with assumptions and unresolved dependencies explicit.
Candidate qualifications
- Show leadership or advice in IPO finance readiness through repeated close, control or reporting rehearsals.
- Provide an example where a green project status did not represent sustainable operating readiness.
- Demonstrate ability to distinguish diligence production from embedded public-company finance capability.
- Evidence senior challenge without assuming accounting, audit, legal or transaction authority.
- Describe a recommendation to pause, condition or re-sequence a public-readiness timetable and its basis.
- Bring broad understanding of finance governance, close, controls, forecasting, talent and evidence expectations.
- Disclose relationships with transaction advisers, investors or providers that could affect independence.
Working terms and boundaries
- The retainer covers three days a week, a weekly clinic, monthly steering session and agreed evidence review.
- Transaction-event attendance, diligence execution or additional travel requires separate written approval.
- The adviser cannot certify readiness, select advisers, make accounting or legal conclusions, or communicate with investors.
- Management owns source evidence, execution, risk acceptance and any transaction decision.
- Relevant adviser, investor and provider interests require continuous disclosure.
Application
Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.
There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 9 October 2026. Mandate reference FNA-ADV-2026-TLV-40.
More seats like this one
This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.